vs
Side-by-side financial comparison of indie Semiconductor, Inc. (INDI) and MEDIFAST INC (MED). Click either name above to swap in a different company.
MEDIFAST INC is the larger business by last-quarter revenue ($75.1M vs $55.5M, roughly 1.4× indie Semiconductor, Inc.). On growth, indie Semiconductor, Inc. posted the faster year-over-year revenue change (2.6% vs -36.9%). Over the past eight quarters, indie Semiconductor, Inc.'s revenue compounded faster (2.9% CAGR vs -34.4%).
indie Semiconductor is a fabless semiconductor manufacturer focused on designing high-performance mixed-signal and embedded system-on-chip solutions for the automotive industry. Its products support advanced driver assistance systems, in-vehicle infotainment, connected car, and electric vehicle applications, serving global auto OEMs and tier 1 suppliers across major global markets.
Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.
INDI vs MED — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $55.5M | $75.1M |
| Net Profit | — | — |
| Gross Margin | 38.0% | 69.4% |
| Operating Margin | -70.1% | -10.4% |
| Net Margin | — | — |
| Revenue YoY | 2.6% | -36.9% |
| Net Profit YoY | — | — |
| EPS (diluted) | — | $-1.64 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $55.5M | — | ||
| Q4 25 | $58.0M | $75.1M | ||
| Q3 25 | $53.7M | $89.4M | ||
| Q2 25 | $51.6M | $105.6M | ||
| Q1 25 | $54.1M | $115.7M | ||
| Q4 24 | $58.0M | $119.0M | ||
| Q3 24 | $54.0M | $140.2M | ||
| Q2 24 | $52.4M | $168.6M |
| Q1 26 | — | — | ||
| Q4 25 | $-31.2M | — | ||
| Q3 25 | $-38.3M | $-2.3M | ||
| Q2 25 | $-39.0M | $2.5M | ||
| Q1 25 | $-34.5M | $-772.0K | ||
| Q4 24 | $-34.4M | — | ||
| Q3 24 | $-49.7M | $1.1M | ||
| Q2 24 | $-19.2M | $-8.2M |
| Q1 26 | 38.0% | — | ||
| Q4 25 | 37.3% | 69.4% | ||
| Q3 25 | 40.1% | 69.5% | ||
| Q2 25 | 40.6% | 72.6% | ||
| Q1 25 | 41.7% | 72.8% | ||
| Q4 24 | 42.6% | 74.1% | ||
| Q3 24 | 39.3% | 75.4% | ||
| Q2 24 | 42.2% | 73.2% |
| Q1 26 | -70.1% | — | ||
| Q4 25 | -58.5% | -10.4% | ||
| Q3 25 | -71.4% | -4.6% | ||
| Q2 25 | -83.3% | -1.0% | ||
| Q1 25 | -72.0% | -1.1% | ||
| Q4 24 | -58.4% | 0.6% | ||
| Q3 24 | -92.5% | 1.5% | ||
| Q2 24 | -70.0% | -4.7% |
| Q1 26 | — | — | ||
| Q4 25 | -53.8% | — | ||
| Q3 25 | -71.3% | -2.5% | ||
| Q2 25 | -75.6% | 2.3% | ||
| Q1 25 | -63.9% | -0.7% | ||
| Q4 24 | -59.2% | — | ||
| Q3 24 | -92.1% | 0.8% | ||
| Q2 24 | -36.6% | -4.8% |
| Q1 26 | — | — | ||
| Q4 25 | $-0.16 | $-1.64 | ||
| Q3 25 | $-0.19 | $-0.21 | ||
| Q2 25 | $-0.20 | $0.22 | ||
| Q1 25 | $-0.18 | $-0.07 | ||
| Q4 24 | $-0.18 | $0.08 | ||
| Q3 24 | $-0.28 | $0.10 | ||
| Q2 24 | $-0.11 | $-0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $174.4M | $167.3M |
| Total DebtLower is stronger | $402.8M | — |
| Stockholders' EquityBook value | $348.9M | $198.9M |
| Total Assets | $869.6M | $248.0M |
| Debt / EquityLower = less leverage | 1.15× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $174.4M | — | ||
| Q4 25 | $145.5M | $167.3M | ||
| Q3 25 | $160.9M | $173.5M | ||
| Q2 25 | $192.6M | $162.7M | ||
| Q1 25 | $236.6M | $164.6M | ||
| Q4 24 | $274.2M | $162.3M | ||
| Q3 24 | $96.9M | $170.0M | ||
| Q2 24 | $112.3M | $163.5M |
| Q1 26 | $402.8M | — | ||
| Q4 25 | $353.4M | — | ||
| Q3 25 | $353.5M | — | ||
| Q2 25 | $352.5M | — | ||
| Q1 25 | $379.0M | — | ||
| Q4 24 | $381.3M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $348.9M | — | ||
| Q4 25 | $358.0M | $198.9M | ||
| Q3 25 | $369.2M | $214.7M | ||
| Q2 25 | $390.4M | $216.0M | ||
| Q1 25 | $405.6M | $211.0M | ||
| Q4 24 | $417.9M | $210.1M | ||
| Q3 24 | $458.6M | $207.3M | ||
| Q2 24 | $470.7M | $205.3M |
| Q1 26 | $869.6M | — | ||
| Q4 25 | $840.8M | $248.0M | ||
| Q3 25 | $855.1M | $268.2M | ||
| Q2 25 | $867.6M | $269.3M | ||
| Q1 25 | $909.0M | $280.0M | ||
| Q4 24 | $941.4M | $284.2M | ||
| Q3 24 | $797.5M | $291.2M | ||
| Q2 24 | $797.3M | $293.5M |
| Q1 26 | 1.15× | — | ||
| Q4 25 | 0.99× | — | ||
| Q3 25 | 0.96× | — | ||
| Q2 25 | 0.90× | — | ||
| Q1 25 | 0.93× | — | ||
| Q4 24 | 0.91× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-5.3M |
| Free Cash FlowOCF − Capex | — | $-6.6M |
| FCF MarginFCF / Revenue | — | -8.8% |
| Capex IntensityCapex / Revenue | — | 1.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-14.4M | $-5.3M | ||
| Q3 25 | $-6.2M | $12.1M | ||
| Q2 25 | $-7.6M | $-3.4M | ||
| Q1 25 | $-29.0M | $3.4M | ||
| Q4 24 | $-6.7M | $-4.9M | ||
| Q3 24 | $-22.8M | $9.1M | ||
| Q2 24 | $-19.7M | $13.1M |
| Q1 26 | — | — | ||
| Q4 25 | $-16.1M | $-6.6M | ||
| Q3 25 | $-10.3M | $10.8M | ||
| Q2 25 | $-13.6M | $-4.8M | ||
| Q1 25 | $-31.4M | $1.9M | ||
| Q4 24 | $-8.6M | $-7.2M | ||
| Q3 24 | $-29.3M | $7.7M | ||
| Q2 24 | $-23.4M | $11.1M |
| Q1 26 | — | — | ||
| Q4 25 | -27.8% | -8.8% | ||
| Q3 25 | -19.2% | 12.0% | ||
| Q2 25 | -26.4% | -4.5% | ||
| Q1 25 | -58.0% | 1.6% | ||
| Q4 24 | -14.8% | -6.1% | ||
| Q3 24 | -54.3% | 5.5% | ||
| Q2 24 | -44.7% | 6.6% |
| Q1 26 | — | — | ||
| Q4 25 | 3.0% | 1.8% | ||
| Q3 25 | 7.8% | 1.5% | ||
| Q2 25 | 11.6% | 1.3% | ||
| Q1 25 | 4.4% | 1.3% | ||
| Q4 24 | 3.2% | 1.9% | ||
| Q3 24 | 12.1% | 1.0% | ||
| Q2 24 | 7.0% | 1.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -1.36× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 8.04× | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
INDI
| Product revenue | $51.6M | 93% |
| Contract revenue | $3.9M | 7% |
MED
Segment breakdown not available.
